12:00 AM
 | 
Jan 03, 2011
 |  BC Week In Review  |  Company News  |  Deals

Martek, Royal DSM deal

Royal DSM will acquire nutraceuticals company Martek in a tender offer for $31.50 per share in cash, or about $1.1 billion. The price is a 35% premium to Martek's close of...

Read the full 131 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >